title: No risk, no benefit: still true for antithrombotic stroke treatments?
authors.affiliation: Department of Neurology, University of Münster, Albert-Schweitzer-Campus 1, 48149 Münster, Germany. minnerup@uni-muenster.de
authors.forename: Jens
authors.initials: J
authors.lastname: Minnerup
authors.forename: Christoph
authors.initials: C
authors.lastname: Kleinschnitz
mesh_terms: D001777:Blood Coagulation / Q000187:drug effects; D001792:Blood Platelets / Q000187:drug effects; D001921:Brain / Q000098:blood supply*; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D020521:Stroke / Q000097:blood / Q000150:complications* / Q000188:drug therapy* / Q000517:prevention & control; D013927:Thrombosis / Q000097:blood / Q000150:complications* / Q000188:drug therapy* / Q000517:prevention & control
chemical_list: D005343:Fibrinolytic Agents